China may join TPP talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

China may join TPP talks

A spokesperson from the Ministry of Commerce (Mofcom) says that China will consider the costs and benefits of entering the TPP negotiations

The 17th round of negotiations of the Trans-Pacific Partnership took place in Peru last month between 12 countries including the United States, Singapore, Vietnam, Australia and New Zealand. Japan joined the talks a month ago.

"We will analyse the advantages, disadvantages and the possibility of joining the TPP, based on careful research and according to principles of equality and mutual benefit," said Shen Danyang of Mofcom.

Some groups have also raised concerns about some of the IP-related provisions in the TPP that have been leaked to the public.

Médecins Sans Frontières called the proposed agreement “the most harmful trade deal ever for access to medicines in developing countries”. According to MSF, one provision would require signatories to allow patents for “modifications of existing medicines, such as a new forms, uses or methods, even without improvement of therapeutic efficacy for patients”.

Some of the leaked provisions concerning copyright have also been criticised. Angela Daly of Swinburne University of Technology in Australia argued that article 4 of the TPP would implement what she describes as controversial aspects of the Digital Millennium Copyright Act, while the Electronic Frontier Foundation said that the TPP in its current form may restrict fair use and impose additional liability on internet service providers.

China’s absence from the TPP negotiations have been noted by some observers, who believe that such an agreement without the world’s second largest economy may be ineffective and would serve to isolate China.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article